Research Into the Effect of Proton Pump Inhibitors on Lungs and Leukocytes

ÖZATİK O., ÖZATİK F. Y., TEKŞEN Y., Dag L., KARADENİZ SAYGILI S., KOÇAK A.

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.32, sa.12, ss.1003-1011, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 12
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/tjg.2021.20550
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1003-1011
  • Anahtar Kelimeler: ARDS, H2 receptors blockers, immune deficiency, lung, proton pump inhibitors, PANTOPRAZOLE
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background: Proton pump inhibitors (PPI) are the most commonly used medication in the world. They are prescribed as an effective treatment choice for gastrointestinal system diseases linked to hyperacidity, especially. Additionally, non-indication and unnecessary use are very common. Many publications in recent times have reported significant side effects. However, there are insufficient studies about the mechanism for these side effects.